VANCOUVER, BRITISH COLUMBIA -- (MARKET WIRE) -- February 19, 2007 -- Pyng Medical Corp. (TSX VENTURE: PYT) is pursuing Chinese FDA (SFDA) regulatory registration in support of launching the FAST1™ Intraosseous Infusion System into The People’s Republic of China. Pyng has retained Beijing Jyton & Kannel Medical Technology Co., Ltd. as its exclusive regulatory representative in China.
